← FDA DRUG APPROVALS

FDA ANDA · ANDA081002

MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE

Sponsor: WEST-WARD PHARMS INT

APPLICATION
ANDA081002
TYPE
ANDA
ORIGINAL APPROVAL
1993-07-30
LATEST ACTION
2025-12-22
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREEPrescription
MEPERIDINE HYDROCHLORIDE 10MG/ML · INJECTABLE · INJECTION

Approval history

2025-12-22Labeling · Supplement 13 · standardAP
2024-01-03Labeling · Supplement 11 · standardAP
2024-01-03Labeling · Supplement 12 · standardAP
2019-10-11Labeling · Supplement 10 · standardAP
2019-09-23Labeling · Supplement 9 · standardAP
2017-05-02Labeling · Supplement 8 · standardAP
1996-05-31Manufacturing (CMC) · Supplement 6AP
1995-09-05Labeling · Supplement 5AP
1995-09-05Labeling · Supplement 4AP
1995-08-29Manufacturing (CMC) · Supplement 3AP
1994-09-29Manufacturing (CMC) · Supplement 1AP
1994-06-10Labeling · Supplement 2AP
1993-07-30OriginalOtherAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →